Virginia Sanzone - Sep 10, 2021 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
VP, General Counsel
Signature
By: Paula Darbyshire, Attorney-in-fact For: Virginia Sanzone
Stock symbol
ICUI
Transactions as of
Sep 10, 2021
Transactions value $
-$201,241
Form type
4
Date filed
9/13/2021, 11:46 AM
Previous filing
May 12, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Sale -$37.8K -151 -6.28% $250.23 2.25K Sep 10, 2021 Direct F1
transaction ICUI Common Stock Sale -$101K -401 -17.79% $251.27 1.85K Sep 10, 2021 Direct F2
transaction ICUI Common Stock Sale -$62.7K -248 -13.38% $252.82 1.61K Sep 10, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $249.76 to $250.72, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $250.88 to $251.83, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.23 to $253.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.